Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes

Expression of mammaglobin and gross cystic disease fluid protein-15 in breast carcinomas

(2013) Ming-Hua Luo et al.   HUMAN PATHOLOGY

Response-Guided Neoadjuvant Chemotherapy for Breast Cancer

(2013) Gunter von Minckwitz et al.   JOURNAL OF CLINICAL ONCOLOGY

Gross cystic disease fluid protein-15 and mammaglobin A expression determined by immunohistochemistry is of limited utility in triple-negative breast cancer

(2012) Lei Huo et al.   HISTOPATHOLOGY

Relationship Between Molecular Subtype of Invasive Breast Carcinoma and Expression of Gross Cystic Disease Fluid Protein 15 and Mammaglobin

(2011) Gloria H. Lewis et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy

(2011) Sibylle Loibl et al.   BREAST CANCER RESEARCH AND TREATMENT

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

(2010) M. Elizabeth H. Hammond et al.   JOURNAL OF CLINICAL ONCOLOGY

EGFR and HER-2/neu expression in invasive apocrine carcinoma of the breast

(2010) Semir Vranic et al.   MODERN PATHOLOGY

Gene expression meta-analysis supports existence of molecular apocrine breast cancer with a role for androgen receptor and implies interactions with ErbB family

(2009) Sandeep Sanga et al.   BMC Medical Genomics

A Functional and Regulatory Network Associated with PIP Expression in Human Breast Cancer

(2009) Marie-Anne Debily et al.   PLoS One

Refinement of breast cancer classification by molecular characterization of histological special types

(2008) B Weigelt et al.   JOURNAL OF PATHOLOGY

Intensified Neoadjuvant Chemotherapy in Early-Responding Breast Cancer: Phase III Randomized GeparTrio Study

(2008) G. von Minckwitz et al.   JNCI-Journal of the National Cancer Institute

Neoadjuvant Vinorelbine-Capecitabine Versus Docetaxel-Doxorubicin-Cyclophosphamide in Early Nonresponsive Breast Cancer: Phase III Randomized GeparTrio Trial

(2008) G. von Minckwitz et al.   JNCI-Journal of the National Cancer Institute